Woodline Partners’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$3.64M Sell
2025
Q1
$4.77M Buy
2022
Q1
Sell
2021
Q4
$5.04M Sell
2021
Q3
$6.69M Buy
2021
Q2
$469K Buy
2021
Q1
Sell
2020
Q4
$6.67M Sell
2020
Q3
$13.7M Buy
2020
Q2
$8.75M Buy
2020
Q1
$4.75M Sell
2019
Q4
$8.04M Buy